New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII)
about
The emerging role of CaMKII in cancerMechanisms of altered Ca²⁺ handling in heart failureMechanisms of sudden cardiac death: oxidants and metabolismCaMKII-dependent responses to ischemia and reperfusion challenges in the heart.Mitochondria and arrhythmias.Three ways to die suddenly: do they all require calcium calmodulin-dependent protein kinase II?Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillationInhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptorActivation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling.Intracellular Na+ overload causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes.Novel aspects of excitation-contraction coupling in heart failure.MicroRNA-23a participates in estrogen deficiency induced gap junction remodeling of rats by targeting GJA1.PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban.S-Nitrosylation Induces Both Autonomous Activation and Inhibition of Calcium/Calmodulin-dependent Protein Kinase II δ.The Use of Gene Therapy for Ablation of Atrial Fibrillation.Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signalStructural studies on the regulation of Ca2+/calmodulin dependent protein kinase IIMolecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts.At-risk but viable myocardium in a large animal model of non ST-segment elevation acute coronary syndrome: cardiovascular magnetic resonance with ex vivo validationActivation-triggered subunit exchange between CaMKII holoenzymes facilitates the spread of kinase activityVisualizing CaMKII and CaM activity: a paradigm of compartmentalized signalingModeling CaMKII-mediated regulation of L-type Ca(2+) channels and ryanodine receptors in the heart.Electrical storm: recent pathophysiological insights and therapeutic consequences.Ca(2+) /calmodulin dependent kinase II: a critical mediator in determining reperfusion outcomes in the heart?Modeling calcium regulation of contraction, energetics, signaling, and transcription in the cardiac myocyte.CaMKII activation promotes cardiac electrical remodeling and increases the susceptibility to arrhythmia induction in high fat diet-fed mice with hyperlipidemia conditions.Calcium/Calmodulin-Dependent Protein Kinase II Activity Persists During Chronic β-Adrenoceptor Blockade in Experimental and Human Heart Failure.CaMKII is a nodal signal for multiple programmed cell death pathways in heart.Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease.Epac2-Rap1 Signaling Regulates Reactive Oxygen Species Production and Susceptibility to Cardiac Arrhythmias.Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absent.Mitochondrial Ca2+ uniporter and CaMKII in heart.Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.Stress Signaling JNK2 Crosstalk with CaMKII Underlies Enhanced Atrial Arrhythmogenesis.[Remodeling of the aging heart : Sinus node dysfunction and atrial fibrillation].Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium.Amelioration of mitochondrial dysfunction in heart failure through S-sulfhydration of Ca/calmodulin-dependent protein kinase IICaveolae-Specific CaMKII Signaling in the Regulation of Voltage-Dependent Calcium Channel and Cardiac Hypertrophy
P2860
Q26995205-72BB5553-3407-4271-8553-FEC0F4425AB9Q27012758-8F203FEE-7FF4-498E-8465-14D4C8D060F5Q27024176-210C5325-33F2-491D-8D56-C30CD45E6BC4Q33600515-988ED42C-B0BF-463D-B024-4714D2AADFE4Q33896746-0091D8AB-FF7B-4D50-B8AF-DC5288656D82Q33957736-E3E17F70-ED5E-48A4-8410-ED0832A63C06Q34002408-C0ED9B5A-6AA0-407B-914C-CB986439CA1BQ34004829-AC8DD7C2-5A59-4E24-A755-2CC5355E51E1Q34387308-6C9F8803-E6BA-47F8-86D6-67E7E5441BB9Q34603278-CBC2A39C-6AF1-4475-9874-AC777CD82F15Q34652710-8E2F67DC-6BD0-4B88-8491-E2A9C223681EQ35197492-A9BDCC14-88B8-44AE-A36B-49C9D8A43D04Q36040250-01724376-A34F-4E27-8BFA-A268A8BA8B6DQ36283384-F6C60018-14C5-45C3-B91E-8823BCCB926FQ36458906-266C106A-8399-4DB4-9089-77F137CD31DBQ36650585-14BF477C-E167-4C1F-909D-801D26474EBFQ37210184-4AE467DB-685D-4F37-9E00-259921E34CF4Q37331050-23BC92F5-DA95-4ADC-86F4-76980BFCA95DQ37366218-550ED472-6396-416C-A601-AC4ED4992B0FQ37511850-6D663D4A-932A-49CD-B750-D21110377498Q37655174-B3A6C0EF-1BB2-40B1-86FB-86ECFB89EE48Q37695297-6087E5A1-69AE-4EA3-BAC3-545FAFB28F4CQ38083549-D97AB321-5CF4-4D3E-BAD1-6BA0DE23EFFFQ38256772-0FAA41BA-0B59-433E-A94B-707C4A967ED8Q38631812-9D4D48E0-00B8-4455-A76B-186E3D93EF6BQ38702432-8F1E6B47-FC29-4AC6-BF7B-27A4B94D43E0Q38795286-C0BCC60E-324F-4B2E-ABA2-1F38F7D28CE4Q39056528-4B088FB7-5326-4A6C-9D18-2BE5F6ED67C1Q39781629-261721BC-C940-4348-B106-E22D929F98A4Q40722220-05F34E97-29D8-49DB-8CA6-4CD68068BC1CQ41016215-2057536A-20B4-44AD-8D42-64CBDDAF7C74Q41273205-51C00FD1-70DD-437F-8DE3-A00CE39CB273Q42413006-6BD33A62-083A-45EF-BB27-2CFD96CE95DDQ42551776-407B4D89-882B-459C-BBA1-AAC376B730D5Q47708298-E972D7F6-DA0F-4A3A-828A-580E54F7F340Q49912067-414D26F5-40E6-4339-A669-1DBDB2EFE77EQ51840493-6833F82C-9350-4BD0-B717-CCDDE70EFF83Q52707811-51EA50D9-7A2E-4CC2-A6C9-E3BF8EC4E43AQ58718425-9C398FB2-9267-43DD-B769-128B4AC38178Q58797256-32C555F4-C876-4653-94CA-D854FD89F1AE
P2860
New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII)
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@ast
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@en
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@nl
type
label
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@ast
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@en
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@nl
prefLabel
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@ast
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@en
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@nl
P2860
P1433
P1476
New therapeutic targets in car ...... n-dependent kinase II (CaMKII)
@en
P2093
A. G. Rokita
M. E. Anderson
P2860
P304
P356
10.1161/CIRCULATIONAHA.112.124990
P407
P577
2012-10-23T00:00:00Z